PURPOSE: To report postoperative results and effectiveness using autogenous sclera as a wrapping material for hydroxyapatite orbital implant. METHODS: A chart review of 78 patients (78 eyes) undergoing primary enucleation or a secondary procedure using autogenous sclera as a wrapping material from March 1997 to October 2004 was undertaken. Primary enucleation was performed in 54 eyes and secondary implantation in 24. In severely constricted eyes or eviscerated eyes with small implants, the sclera was unfolded and used for wrapping only on the anterior surface of the implant. RESULTS: The average size of implants was 19.7 mm in diameter, and all the 78 implants were over 18 mm. During an average postoperative follow-up of 18 months, complications such as implant exposure, infection or extrusion did not occur in any case. CONCLUSION: This study shows that autogenous sclera is a safe, effective wrapping material for hydroxyapatite orbital implants with no serious complications. Copyright 2008 S. Karger AG, Basel.
PURPOSE: To report postoperative results and effectiveness using autogenous sclera as a wrapping material for hydroxyapatite orbital implant. METHODS: A chart review of 78 patients (78 eyes) undergoing primary enucleation or a secondary procedure using autogenous sclera as a wrapping material from March 1997 to October 2004 was undertaken. Primary enucleation was performed in 54 eyes and secondary implantation in 24. In severely constricted eyes or eviscerated eyes with small implants, the sclera was unfolded and used for wrapping only on the anterior surface of the implant. RESULTS: The average size of implants was 19.7 mm in diameter, and all the 78 implants were over 18 mm. During an average postoperative follow-up of 18 months, complications such as implant exposure, infection or extrusion did not occur in any case. CONCLUSION: This study shows that autogenous sclera is a safe, effective wrapping material for hydroxyapatite orbital implants with no serious complications. Copyright 2008 S. Karger AG, Basel.